CONTRAST-INDUCED ACUTE KIDNEY INJURY
Clinical trials for CONTRAST-INDUCED ACUTE KIDNEY INJURY explained in plain language.
Never miss a new study
Get alerted when new CONTRAST-INDUCED ACUTE KIDNEY INJURY trials appear
Sign up with your email to follow new studies for CONTRAST-INDUCED ACUTE KIDNEY INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drugs tested as shield for kidneys during heart scans
Prevention Recruiting nowThis study looks at whether a common class of diabetes drugs, called SGLT2 inhibitors (flozins), can help prevent kidney injury caused by the contrast dye used during heart imaging and procedures. Researchers are reviewing the medical records of 4,000 patients who had these heart…
Matched conditions: CONTRAST-INDUCED ACUTE KIDNEY INJURY
Sponsor: Collegium Medicum w Bydgoszczy • Aim: Prevention
Last updated Apr 01, 2026 14:43 UTC
-
New IV strategy aims to stop common kidney damage after heart scans
Prevention Recruiting nowThis study is testing whether a personalized IV fluid plan can prevent kidney damage that sometimes occurs after common heart procedures like angiograms or stents. Over 1,100 patients will receive either a standard fluid rate or a rate adjusted based on their heart pressure and t…
Matched conditions: CONTRAST-INDUCED ACUTE KIDNEY INJURY
Phase: NA • Sponsor: Montreal Heart Institute • Aim: Prevention
Last updated Mar 30, 2026 14:35 UTC
-
New drug aims to stop common kidney damage after heart scans
Prevention Recruiting nowThis study is testing whether a new oral medication called APX-115 can prevent kidney damage caused by the dye used during common heart procedures. It will involve about 280 adults with reduced kidney function who are scheduled for a coronary angioplasty. Participants will be ran…
Matched conditions: CONTRAST-INDUCED ACUTE KIDNEY INJURY
Phase: PHASE2 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Prevention
Last updated Mar 23, 2026 15:19 UTC